Načítá se...

Thioredoxin decreases anthracycline cardiotoxicity, but sensitizes cancer cell apoptosis

Cardiotoxicity is a major limitation for anthracycline chemotherapy although anthracyclines are potent antitumor agents. The precise mechanism underlying clinical heart failure due to anthracycline treatment is not fully understood, but is believed to be due, in part, to lipid peroxidation and the g...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cardiovasc Toxicol
Hlavní autoři: Das, Kumuda C., Muniyappa, Harish, Kundumani-Sridharan, Venkatesh, Subramani, Jaganathan
Médium: Artigo
Jazyk:Inglês
Vydáno: 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7854973/
https://ncbi.nlm.nih.gov/pubmed/32880787
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12012-020-09605-2
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!